Tatsuhiko Tachibana

This inventor holds 21 USPTO granted patents and 29 published patent applications, plus 1 CIPO patent and 14 EPO patents, primarily in Antibody Engineering. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tatsuhiko Tachibana. Retrieved from https://idiyas.com/inventor/tatsuhiko-tachibana

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 21 (Patent Applications = 29)

% Patents Active = 95.2

CIPO Patents = 1 (Patent Applications = 2)

EPO Patents = 14 (Patent Applications = 19)

Average Co-Inventor Count = 5.4

ph-index = 12

Forward Citations = 393(Granted Patents)

Company Filing History:

21 out of 987

Chugai Seiyaku Kabushiki Kaisha

patents

Years Active: 2013-2026

Loading Chart...

Areas of Expertise:

Antibody

Pharmacokinetics

Isoelectric Point

Immune Response

Antigen-Binding Molecule

IL-6

IL-8

Humanized Antibody

Cancer Therapeutics

Nucleic Acids

Anti-AXL

Anti-Glypican-3

21 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12595299 - FC variants (2026-04-07),

2. 12473375 - METHODS FOR CONTROLLING BLOOD PHARMACOKINETICS OF ANTIBODIES (2025-11-18),

3. 12371485 - Antigen-binding molecule inducing immune response to target antigen (2025-07-29),

4. 12122840 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2024-10-22),

5. 12116414 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2024-10-15),

6. 11718678 - Method for altering plasma retention and immunogenicity of antigen-binding molecule (2023-08-08),

7. 11248053 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2022-02-15),

8. 11180548 - Methods of neutralizing IL-8 biological activity (2021-11-23),

9. 11046784 - Methods for controlling blood pharmacokinetics of antibodies (2021-06-29),

10. 10662245 - Methods of reducing IL-6 activity for disease treatment (2020-05-26),

11. 10618965 - Method for altering plasma retention and immunogenicity of antigen-binding molecule (2020-04-14),

12. 10556949 - Antigen-binding molecule inducing immune response to target antigen (2020-02-11),

13. 10519229 - Nucleic acids encoding IL-8 antibodies (2019-12-31),

14. 9828429 - Method of modifying isoelectric point of antibody via amino acid substitution in CDR (2017-11-28),

15. 9556264 - Humanized anti-epiregulin antibody, and cancer therapeutic agent comprising said antibody as active ingredient (2017-01-31),

Title: The Innovative Journey of Tatsuhiko Tachibana

Introduction:

Tatsuhiko Tachibana, a visionary inventor hailing from Shizuoka, Japan, has made significant contributions to the field of technology through his groundbreaking innovations and patents.

Latest Patents:

Tachibana's recent patents focus on advancements in renewable energy technologies, particularly in the development of efficient solar panels and energy storage solutions that have the potential to revolutionize the way we harness and utilize clean energy.

Career Highlights:

With a background in engineering and a passion for sustainable solutions, Tatsuhiko Tachibana has spent decades pushing the boundaries of what is possible in the realm of renewable energy. His work has not only earned him recognition within the industry but has also paved the way for a more sustainable future.

Collaborations:

Throughout his career, Tachibana has collaborated with leading research institutions and technology companies to bring his inventions to life. His ability to work across disciplines and bring together diverse teams has been instrumental in the success of his projects.

Conclusion:

In conclusion, Tatsuhiko Tachibana stands as a true innovator in the field of renewable energy, with a track record of turning ambitious ideas into tangible solutions. His dedication to creating a more sustainable world serves as an inspiration to inventors and researchers around the globe.

Profile summary based on public USPTO records.